MUC1 peptide-loaded dendritic cell vaccine boosts antitumor immunity in pancreatic cancer
ObjectivePancreatic cancer is one of the most aggressive malignancies with a poor prognosis and limited treatment options. This study aimed to evaluate the efficacy of a dendritic cell (DC) vaccine pulsed with mucin 1 (MUC1) peptide antigens in the imm…